Year: 2022

TSTN_Logo_Twitter-1

Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy

SAN DIEGO--(BUSINESS WIRE)--#NCI--Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors, today announced...